• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞中 FoxP3 异构体和 PD-1 的表达与多发性硬化症。

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis.

机构信息

Laboratory of Neuroimmunology, Fondazione Santa Lucia, Rome, 00143, Italy.

Institute of Experimental Oncology and Endocrinology, National Research Council (IEOS-CNR), Treg Cell Lab, Naples, 80131, Italy.

出版信息

Sci Rep. 2018 Feb 27;8(1):3674. doi: 10.1038/s41598-018-21861-5.

DOI:10.1038/s41598-018-21861-5
PMID:29487369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5829149/
Abstract

Forkhead box P3 (FoxP3)+ regulatory T cells (Treg) are powerful mediators of immune regulation and immune homeostasis. In humans, Tregs are a heterogeneous population expressing surface markers which define phenotypically and functionally distinct subsets. Moreover, it is now clear that intracellular staining for FoxP3 does not unequivocally identify "true" suppressor cells, since several FoxP3 isoforms exist, and different reagents for FoxP3 detection are available. Here, we propose a strategy to identify potentially functional and suppressive Treg cells in an autoimmune disease like multiple sclerosis, and we suggest that in patients affected by this disease these cells are both reduced in number and functionally exhausted.

摘要

叉头框蛋白 P3(FoxP3)+调节性 T 细胞(Treg)是免疫调节和免疫稳态的强大介质。在人类中,Tregs 是一个异质性群体,表达表面标记物,这些标记物定义了表型和功能上不同的亚群。此外,现在很清楚,FoxP3 的细胞内染色不能明确识别“真正”的抑制细胞,因为存在几种 FoxP3 异构体,并且有不同的 FoxP3 检测试剂可用。在这里,我们提出了一种在多发性硬化症等自身免疫性疾病中识别潜在功能和抑制性 Treg 细胞的策略,我们认为在患有这种疾病的患者中,这些细胞的数量减少且功能耗竭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/b7034866b97e/41598_2018_21861_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/43d9fb27cc38/41598_2018_21861_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/c45cf16a1049/41598_2018_21861_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/e88f785f25fe/41598_2018_21861_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/49f5bca984ad/41598_2018_21861_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/b7034866b97e/41598_2018_21861_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/43d9fb27cc38/41598_2018_21861_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/c45cf16a1049/41598_2018_21861_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/e88f785f25fe/41598_2018_21861_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/49f5bca984ad/41598_2018_21861_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ece1/5829149/b7034866b97e/41598_2018_21861_Fig5_HTML.jpg

相似文献

1
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis.调节性 T 细胞中 FoxP3 异构体和 PD-1 的表达与多发性硬化症。
Sci Rep. 2018 Feb 27;8(1):3674. doi: 10.1038/s41598-018-21861-5.
2
Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.活动期泛发性白癜风患者调节性 T 细胞及程序性死亡受体 1 表达的调节性 T 细胞的改变及其临床相关性。
Br J Dermatol. 2015 Apr;172(4):940-50. doi: 10.1111/bjd.13511. Epub 2015 Feb 27.
3
In-vitro effect of pembrolizumab on different T regulatory cell subsets.帕博利珠单抗对不同 T 调节细胞亚群的体外作用。
Clin Exp Immunol. 2018 Feb;191(2):189-197. doi: 10.1111/cei.13060. Epub 2017 Nov 3.
4
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.新型自身免疫性胰腺炎小鼠模型中PD-1和FoxP3在维持免疫耐受中的非重叠作用
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8490-5. doi: 10.1073/pnas.1608873113. Epub 2016 Jul 7.
5
Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.抗肿瘤坏死因子治疗期间炎症性肠病中Foxp3 +调节性T细胞亚群和Foxp3 - 1型调节样T细胞的恢复
Inflamm Bowel Dis. 2015 Oct;21(10):2418-28. doi: 10.1097/MIB.0000000000000509.
6
CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.CD39+Foxp3+调节性T细胞抑制致病性Th17细胞,且在多发性硬化症中功能受损。
J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.
7
Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.复发缓解型多发性硬化症患者中,CD4+ CD25(高表达)调节性T细胞功能受损与FOXP3阳性细胞频率降低以及单细胞水平上FOXP3表达降低相关。
Immunology. 2008 Jan;123(1):79-89. doi: 10.1111/j.1365-2567.2007.02690.x. Epub 2007 Sep 25.
8
Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.人脐静脉内皮细胞通过程序性死亡配体1(PD-L1)促进CD4(+)CD25(+)Foxp3(+)调节性T细胞的抑制性活化。
Atherosclerosis. 2016 Jan;244:108-12. doi: 10.1016/j.atherosclerosis.2015.11.002. Epub 2015 Nov 6.
9
FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.FOXP3 去甲基化作为鉴定急性冠脉综合征中调节性 T 细胞数量缺陷的一种方法。
Atherosclerosis. 2013 Jul;229(1):263-70. doi: 10.1016/j.atherosclerosis.2013.05.007. Epub 2013 May 16.
10
IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.IL-15 干扰了乳糜泻患者肠道调节性 T 细胞扩增后的抑制活性。
Am J Gastroenterol. 2011 Jul;106(7):1308-17. doi: 10.1038/ajg.2011.80. Epub 2011 Apr 5.

引用本文的文献

1
Armored human CAR T cells with PD1 promoter-driven IL-10 have enhanced suppressive function.具有PD1启动子驱动的IL-10的装甲人类嵌合抗原受体T细胞具有增强的抑制功能。
Sci Adv. 2025 Jun 13;11(24):eadx7845. doi: 10.1126/sciadv.adx7845.
2
Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course.肌萎缩侧索硬化症病程中调节性T细胞水平及表型改变
Front Immunol. 2025 Jan 8;15:1508974. doi: 10.3389/fimmu.2024.1508974. eCollection 2024.
3
Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease.

本文引用的文献

1
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.具有高度免疫抑制特性的调节性T细胞在乳腺肿瘤微环境中的优先积累。
Oncotarget. 2017 May 16;8(20):33159-33171. doi: 10.18632/oncotarget.16565.
2
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.T细胞共刺激受体CD28是PD-1介导抑制作用的主要靶点。
Science. 2017 Mar 31;355(6332):1428-1433. doi: 10.1126/science.aaf1292. Epub 2017 Mar 9.
3
Human CD39 regulatory T cells present stronger stability and function under inflammatory conditions.
银屑病关节炎中调节性T细胞的深度表型分析揭示了可靶向的疾病机制。
J Biol Chem. 2025 Jan;301(1):108059. doi: 10.1016/j.jbc.2024.108059. Epub 2024 Dec 9.
4
The epigenetic modification of DNA methylation in neurological diseases.神经疾病中的 DNA 甲基化的表观遗传修饰。
Front Immunol. 2024 Sep 23;15:1401962. doi: 10.3389/fimmu.2024.1401962. eCollection 2024.
5
Limitations and potential strategies of immune checkpoint blockade in age-related neurodegenerative disorders.免疫检查点阻断在与年龄相关的神经退行性疾病中的局限性和潜在策略。
J Physiol Sci. 2024 Sep 23;74(1):46. doi: 10.1186/s12576-024-00933-4.
6
An autoimmune transcriptional circuit drives FOXP3 regulatory T cell dysfunction.自身免疫转录电路驱动 FOXP3 调节性 T 细胞功能障碍。
Sci Transl Med. 2024 Aug 28;16(762):eadp1720. doi: 10.1126/scitranslmed.adp1720.
7
The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy.组蛋白乳酰化对肿瘤微环境和代谢途径的影响及其在癌症治疗中的潜力。
Genes Genomics. 2024 Sep;46(9):991-1011. doi: 10.1007/s13258-024-01554-2. Epub 2024 Aug 10.
8
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression.调节性 T 细胞(Tregs)在肿瘤微环境中的复杂作用:其分子机制及其对癌症进展的双向影响。
Int J Mol Sci. 2024 Jul 4;25(13):7346. doi: 10.3390/ijms25137346.
9
Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?调节性 T 细胞的多面性:异质性还是可塑性?
Cells. 2024 Jun 1;13(11):959. doi: 10.3390/cells13110959.
10
Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients.诱导FoxP3前体信使核糖核酸可变剪接以增强肌萎缩侧索硬化症患者调节性T细胞的抑制活性
Biomedicines. 2024 May 7;12(5):1022. doi: 10.3390/biomedicines12051022.
人CD39调节性T细胞在炎症条件下表现出更强的稳定性和功能。
Cell Mol Immunol. 2017 Jun;14(6):521-528. doi: 10.1038/cmi.2016.30. Epub 2016 Jul 4.
4
PD-1 marks dysfunctional regulatory T cells in malignant gliomas.程序性死亡受体1(PD-1)标记恶性胶质瘤中功能失调的调节性T细胞。
JCI Insight. 2016 Apr 21;1(5). doi: 10.1172/jci.insight.85935.
5
TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.通过CD39和CD45RO的表达鉴定的CD4(+)CD25(hi) T细胞内两个不同的FOXP3(+)调节性T细胞亚群的TCR使用情况、基因表达和功能。
Immunol Cell Biol. 2016 Mar;94(3):293-305. doi: 10.1038/icb.2015.90. Epub 2015 Oct 15.
6
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis.肿瘤浸润性FoxP3 +调节性T细胞在癌症中的预后价值:一项系统评价和荟萃分析
Sci Rep. 2015 Oct 14;5:15179. doi: 10.1038/srep15179.
7
IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.白细胞介素-1β通过诱导叉头框蛋白3(FOXP3)的可变剪接促进辅助性T细胞17(Th17)分化。
Sci Rep. 2015 Oct 6;5:14674. doi: 10.1038/srep14674.
8
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.糖酵解通过调节FOXP3外显子2剪接变体的表达来控制人类调节性T细胞的诱导。
Nat Immunol. 2015 Nov;16(11):1174-84. doi: 10.1038/ni.3269. Epub 2015 Sep 28.
9
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?是时候将目标设定为多发性硬化症的无明显疾病活动(NEDA)了吗?
Mult Scler Relat Disord. 2015 Jul;4(4):329-33. doi: 10.1016/j.msard.2015.04.006. Epub 2015 May 8.
10
Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.活动期泛发性白癜风患者调节性 T 细胞及程序性死亡受体 1 表达的调节性 T 细胞的改变及其临床相关性。
Br J Dermatol. 2015 Apr;172(4):940-50. doi: 10.1111/bjd.13511. Epub 2015 Feb 27.